Showing 141 - 160 results of 754 for search '"Pharmacokinetics"', query time: 0.05s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149

    Rationale and design of a prospective study evaluating population pharmacokinetics and pharmacodynamics of rivaroxaban in Chinese patients with non-valvular atrial fibrillation by Ming-Ming Yan, Xiao-Qin Liu, Yu-Fei Zhang, Hong-Yan Ding, Ming-Kang Zhong, Chun-Lai Ma

    Published 2022-06-01
    “…Few studies have investigated the pharmacokinetics (PK) and pharmacodynamics (PD) of rivaroxaban in Chinese patients and provided a solid reference for dose selection and individualised therapy.Methods and analysis This is a single-centre prospective study. …”
    Get full text
    Article
  10. 150

    An UPLC-MS/MS Method for Determination of Osimertinib in Rat Plasma: Application to Investigating the Effect of Ginsenoside Rg3 on the Pharmacokinetics of Osimertinib by Zhenzhen Ying, Jingyao Wei, Ruijuan Liu, Fang Zhao, Yifang Yu, Xin Tian

    Published 2020-01-01
    “…There was a further investigation on the effects of multiple doses of ginsenoside Rg3 on the pharmacokinetics of osimertinib in rats for the first time. …”
    Get full text
    Article
  11. 151
  12. 152
  13. 153

    Determination and Pharmacokinetics of Okanin in Rat Plasma by UltraHigh Performance Liquid Chromatography Coupled with Triple-Quadrupole Tandem Mass Spectrometry by Yurui Shi, Rongda Chen, Jing Xie, Li Li, Guiming Liu, Meizhu Zheng, Ning Zhang

    Published 2020-01-01
    “…The stability, matrix effect, extraction recovery, accuracy, precision, linearity, and selectivity of the method were firstly demonstrated. The major pharmacokinetic parameters of okanin in rat plasma were then measured using the developed UPLC-MS method. …”
    Get full text
    Article
  14. 154
  15. 155
  16. 156
  17. 157

    In vitro and in silico Anti-diabetes mechanism of phytochemicals from Curculigo pilosa and its pharmacokinetic profiling via α-amylase inhibition by Damilola A. Omoboyowa, Temitope C. Aribigbola, Simbo T. Akinsulure, Damilola S. Bodun, Ezekiel A. Olugbogi, Ebenezer A. Oni

    Published 2025-06-01
    “…Some of the compounds showed appreciable inhibitory pIC50 and fitness scores comparable to the standard drug. The pharmacokinetic profile revealed that none of the compounds violated more than one Lipinski's rule of five while the standard drug (acarbose) violated three (3) of the rules. …”
    Get full text
    Article
  18. 158
  19. 159
  20. 160